506690 Stock Overview
A pharmaceutical company, manufactures and sells pharmaceutical products worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Unichem Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹856.10 |
| 52 Week High | ₹949.85 |
| 52 Week Low | ₹401.10 |
| Beta | 0.13 |
| 11 Month Change | 6.69% |
| 3 Month Change | 43.59% |
| 1 Year Change | 106.16% |
| 33 Year Change | 259.86% |
| 5 Year Change | 421.54% |
| Change since IPO | 511.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| 506690 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -4.3% | 0.5% | 0.5% |
| 1Y | 106.2% | 42.5% | 27.5% |
Return vs Industry: 506690 exceeded the Indian Pharmaceuticals industry which returned 42.5% over the past year.
Return vs Market: 506690 exceeded the Indian Market which returned 27.5% over the past year.
Price Volatility
| 506690 volatility | |
|---|---|
| 506690 Average Weekly Movement | 6.8% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 506690 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 506690's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1944 | 2,875 | Pabitra Kumar Bhattacharya | www.unichemlabs.com |
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services.
Unichem Laboratories Limited Fundamentals Summary
| 506690 fundamental statistics | |
|---|---|
| Market cap | ₹60.27b |
| Earnings (TTM) | -₹55.64m |
| Revenue (TTM) | ₹17.75b |
3.4x
P/S Ratio-1,083x
P/E RatioIs 506690 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 506690 income statement (TTM) | |
|---|---|
| Revenue | ₹17.75b |
| Cost of Revenue | ₹7.27b |
| Gross Profit | ₹10.48b |
| Other Expenses | ₹10.54b |
| Earnings | -₹55.64m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.79 |
| Gross Margin | 59.06% |
| Net Profit Margin | -0.31% |
| Debt/Equity Ratio | 11.2% |
How did 506690 perform over the long term?
See historical performance and comparison